Gordon I. McPhie

423 total citations
8 papers, 333 citations indexed

About

Gordon I. McPhie is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Small Animals. According to data from OpenAlex, Gordon I. McPhie has authored 8 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 1 paper in Small Animals. Recurrent topics in Gordon I. McPhie's work include Nicotinic Acetylcholine Receptors Study (6 papers), Receptor Mechanisms and Signaling (5 papers) and Ion channel regulation and function (3 papers). Gordon I. McPhie is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (6 papers), Receptor Mechanisms and Signaling (5 papers) and Ion channel regulation and function (3 papers). Gordon I. McPhie collaborates with scholars based in United Kingdom, United States and Italy. Gordon I. McPhie's co-authors include Emanuele Sher, Ruud Zwart, Giovanna De Filippi, Lisa M. Broad, Giovanni Benedetti, Karl H. Pearson, Stephen Baker, Yelin Chen, Louise Wallace and Peter J. Craig and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, European Journal of Pharmacology and Neuropharmacology.

In The Last Decade

Gordon I. McPhie

7 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gordon I. McPhie United Kingdom	7	304	99	81	25	16	8	333
Dustin K. Williams United States	7	435 1.4×	116 1.2×	91 1.1×	26 1.0×	14 0.9×	7	488
Victor B. Cockcroft United Kingdom	8	373 1.2×	213 2.2×	60 0.7×	17 0.7×	11 0.7×	11	445
Anna L. Carbone Germany	9	404 1.3×	186 1.9×	60 0.7×	22 0.9×	7 0.4×	11	445
Karin Sandager‐Nielsen Denmark	10	221 0.7×	136 1.4×	40 0.5×	13 0.5×	14 0.9×	15	299
Hilde Ween United States	9	474 1.6×	126 1.3×	119 1.5×	26 1.0×	7 0.4×	11	494
Non Evans United Kingdom	7	245 0.8×	195 2.0×	58 0.7×	9 0.4×	16 1.0×	8	343
Justin R. King United States	6	298 1.0×	93 0.9×	49 0.6×	19 0.8×	6 0.4×	16	354
Kirsten Thorin‐Hagene United States	8	439 1.4×	115 1.2×	105 1.3×	24 1.0×	5 0.3×	10	457
P.J. Corringer France	4	406 1.3×	187 1.9×	37 0.5×	17 0.7×	4 0.3×	6	441

Countries citing papers authored by Gordon I. McPhie

Since Specialization

Citations

This map shows the geographic impact of Gordon I. McPhie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon I. McPhie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon I. McPhie more than expected).

Fields of papers citing papers by Gordon I. McPhie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon I. McPhie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon I. McPhie. The network helps show where Gordon I. McPhie may publish in the future.

Co-authorship network of co-authors of Gordon I. McPhie

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon I. McPhie. A scholar is included among the top collaborators of Gordon I. McPhie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon I. McPhie. Gordon I. McPhie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

McPhie, Gordon I., et al.. (2014). Incorporation of cardiovascular safety pharmacology endpoints in toxicology studies in the minipig. Toxicology Letters. 229. S219–S220.

McPhie, Gordon I., et al.. (2010). An integrated cardiovascular and neurobehavioural functional assessment in the conscious telemetered cynomolgus monkey. Journal of Pharmacological and Toxicological Methods. 62(2). 95–106. 17 indexed citations

Broad, Lisa M., Ruud Zwart, Martin Lee, et al.. (2006). Identification and Pharmacological Profile of a New Class of Selective Nicotinic Acetylcholine Receptor Potentiators. Journal of Pharmacology and Experimental Therapeutics. 318(3). 1108–1117. 68 indexed citations

Sher, Emanuele, Yelin Chen, Giovanni Benedetti, et al.. (2004). Physiological Roles of Neuronal Nicotinic Receptors Subtypes: New Insights on the Nicotinic Modulation of Neurotransmitter Release, Synaptic Transmission and Plasticity. Current Topics in Medicinal Chemistry. 4(3). 283–297. 75 indexed citations

Craig, Peter J., Suchira Bose, Ruud Zwart, et al.. (2004). Stable expression and characterisation of a human α7 nicotinic subunit chimera: a tool for functional high-throughput screening. European Journal of Pharmacology. 502(1-2). 31–40. 24 indexed citations

Evans, Non, Suchira Bose, Giovanni Benedetti, et al.. (2003). Expression and functional characterisation of a human chimeric nicotinic receptor with α6β4 properties. European Journal of Pharmacology. 466(1-2). 31–39. 35 indexed citations

Broad, Lisa M., Ruud Zwart, Gordon I. McPhie, et al.. (2002). PSAB-OFP, a selective α7 nicotinic receptor agonist, is also a potent agonist of the 5-HT3 receptor. European Journal of Pharmacology. 452(2). 137–144. 27 indexed citations

Zwart, Ruud, et al.. (2002). 5-Hydroxyindole potentiates human α7 nicotinic receptor-mediated responses and enhances acetylcholine-induced glutamate release in cerebellar slices. Neuropharmacology. 43(3). 374–384. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact